Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73850243)
Watch
English
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
scientific article published on 01 October 1997
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
title
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
main subject
microsphere
1 reference
based on heuristic
inferred from title
leuprolide
1 reference
based on heuristic
inferred from title
author name string
Okada H
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
publication date
1 October 1997
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
published in
Advanced Drug Delivery Reviews
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
volume
28
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
page(s)
43-70
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
cites work
Synthetic analogs of luteinizing hormone releasing hormone (LH-RH) substituted in position 6 and 10.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leuprolide versus diethylstilbestrol for metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrine-dependent rat mammary tumor regression: use of a gonadotropin releasing hormone analog
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats II: mechanism of absorption enhancement with organic acids.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats III: Effect of estrous cycle on vaginal absorption of hydrophilic model compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Desensitization of gonadotropin-releasing response following vaginal consecutive administration of leuprolide in rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Once-a-Month Injectable Microcapsules of Leuprorelin Acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biodegradable microspheres in drug delivery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy and safety of a new leuprorelin acetate depot formulation in patients with advanced prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interim report of a large French multicentre study of efficacy and safety of 3.75 mg leuprorelin depot in metastatic prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of leuprorelin acetate depot for prostate cancer. The German Leuprorelin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone. Analogue depot therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Depot leuprolide acetate dosage for sexual precocity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Two-year results of treatment with depot leuprolide acetate for central precocious puberty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-acting delivery systems for narcotic antagonists. 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New method for analysis of biodegradable polyesters by high-performance liquid chromatography after alkali hydrolysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histologic comparison of polylactic and polyglycolic acid sutures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tissue response to biodegradable injectable microcapsules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) Microspheres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A New Long-Acting Injectable Microcapsule System for the Administration of Progesterone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A month-long effect from a single injection of microencapsulated human growth hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stabilization of nerve growth factor in controlled release polymers and in tissue.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preparation and in vitro degradation properties of polylactide microcapsules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A radioimmunoassay for a highly active luteinizing hormone-releasing hormone analogue and relation between the serum level of the analogue and that of gonadotropin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900050-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0169-409X(97)00050-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
PubMed publication ID
10837564
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10837564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837564%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit